Taken together, these data suggested that IL6-JAK-STAT3 signal pathway played a significant role in the pathogenesis of ccRCC, providing the rationale of targeting this pathway in ccRCC treatment. Here, IL6 is linked to nonpapillary renal cell carcinoma.